Optiver Holding’s Filana Therapeutics FLNA Stock Holding History

Optiver Holding’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,851	Closed	-$4.82K	–	3045
2026 Q1	$4.82K	Buy	+2,851	New	+$5.87K	﹤0.01%	1440
2025 Q4	–	Sell	-12	Closed	-$35	–	2924
2025 Q3	$35	Buy	+12	New	+$28	﹤0.01%	2630

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Optiver Holding's FLNA Position: Q2 2026 in Review

Optiver Holding sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 2,851 shares — an estimated $4.82K sold.

Optiver Holding first reported a position in FLNA in Q3 2025 and held it in 2 quarters. The position peaked at $4.82K in Q1 2026. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Optiver Holding reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 2,851 Filana Therapeutics shares in Q2 2026, an estimated $4.82K.
Optiver Holding first reported a position in Filana Therapeutics in Q3 2025 and held it in 2 quarters.
Optiver Holding's Filana Therapeutics position peaked at $4.82K in Q1 2026.
84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.